Related Experiment Videos
Evaluation of the supertransfusion regimen in homozygous beta-thalassaemia children
Insights
Maintaining higher hemoglobin levels in thalassemia major patients through supertransfusion regimens does not significantly increase blood consumption after an initial adjustment period. This supports better patient management and tissue oxygenation.
Area of Science:
- Hematology
- Transfusion Medicine
Background:
- Physiological hemoglobin levels are crucial for managing thalassemia major.
- Benefits include improved tissue oxygenation and reduced iron absorption.
Purpose of the Study:
- To compare blood consumption between standard and supertransfusion regimens in thalassemia major patients.
- To assess the long-term impact of higher hemoglobin targets on transfusion needs.
Main Methods:
- A study involving 11 thalassemia major patients.
- Two treatment periods: standard transfusion (Hb 10.2 g/dl) and supertransfusion (Hb 12.3 g/dl).
- Blood consumption was monitored over 4-18 months.
Main Results:
- Initial increase in blood consumption observed during the supertransfusion regimen's equilibration phase.
- Blood consumption returned to baseline levels after 5 months.
- No significant difference in blood consumption between regimens after the equilibration period.
Conclusions:
- Supertransfusion regimens for thalassemia major are feasible without significantly increasing long-term blood requirements.
- Higher hemoglobin targets can be maintained effectively, potentially improving patient outcomes.
Abstract:
The maintenance of physiological levels of haemoglobin is beneficial in the management of patients with thalassaemia major since it leads to better tissue oxygenation, reduction of blood volume, and reduced intestinal absorption of iron. We have studied 11 patients with thalassaemia major while treating them for 4-12 months with a standard transfusion regimen (mean pre-transfusion Hb 10.2 g/dl) and then for a second period of 7-18 months with a supertransfusion regimen (mean pre-transfusion Hb 12.3 g/dl). Blood consumption was 16.71 +/- 2.0 ml/kg/month in the first period; it rose to 20.30 +/- 3.5 ml/kg/month in the first 5 months of the second period, and then returned to the values of the first period (16.53 +/0 2.0 ml/kg/month). There were no significant differences in blood consumption between the two transfusion regimens, after the 5-month equilibration period.